NCT04545671 is a clinical trial of trifocal lens in Cataract Senile, sponsored by Carl Zeiss Meditec AG.

Who is sponsoring NCT04545671?

NCT04545671 is sponsored by Carl Zeiss Meditec AG.

What drugs are being tested in NCT04545671?

Interventions in NCT04545671: trifocal lens.

What condition does NCT04545671 study?

NCT04545671 studies Cataract Senile.

Is NCT04545671 still recruiting?

NCT04545671 is currently completed. Last updated 20 July 2022.

Last reviewed 2022-07-20 · How we verify

NCT04545671

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluation of a Trifocal Lens

Completed Last updated 20 July 2022

What this trial tests

trial testing trifocal lens in Cataract Senile in 389 participants. Completed in 16 March 2022.

Timeline

1 November 2020

Primary endpoint
16 March 2022

16 March 2022

Quick facts

Lead sponsor	Carl Zeiss Meditec AG
Status	Completed
Study type	OBSERVATIONAL
Enrollment	389
Start date	1 November 2020
Primary completion	16 March 2022
Estimated completion	16 March 2022
Sites	1 location across Germany

Drugs / interventions tested

trifocal lens

Conditions studied

Cataract Senile — all drugs for Cataract Senile →

Sponsor

Carl Zeiss Meditec AG — full company profile →

Who can join

45 and older, any sex, with Cataract Senile. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Evaluation of the clinical safety and effectiveness of hydrophilic acrylic intraocular lens

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of trifocal lens

Trials testing the same drug.

NCT03586271 — Comparison of the Visual Performance After Implantation of Multifocal Lens · unknown

Other recruiting trials for Cataract Senile

Currently open trials in the same condition.

NCT04570579 — Impact of a Novel Extended Depth of Focus Intraocular Lens on Visual and Lifestyle Enhancement · active not recruiting

Other Carl Zeiss Meditec AG trials

Trials by the same sponsor.

NCT07471295 — Toric Performance And Constant Evaluation · Phase 4 · not yet recruiting
NCT07297719 — Evaluation of Glistening, Visual Outcomes and General Safety 24 Months Post-IOL Implantation · completed
NCT06192901 — Safety and Performance of Hydrophobic and Hydrophilic Intraocular Lenses After Bilateral Cataract Surgery · completed
NCT06247683 — Study to Confirm Safety and Performance of a New Multifocal IOL · NA · completed
NCT05646004 — 621 Real World Study · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04545671 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Carl Zeiss Meditec AG
Last refreshed: 20 July 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04545671.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing